(Reuters) – The US Food and Drug Administration said on Thursday that cyber security vulnerabilities were identified in Medtronic PLC's implantable heart devices, clinic programmers, and home monitors.
But the FDA recommended the use of the devices and said that the medical device manufacturer developed updates to further mitigate these vulnerabilities. The health regulator added that it was not aware of any reports that patients were injured.
Last year, Medtronic closed internet updates for about 34,000 CareLink programming devices that healthcare providers around the world are using to access implanted pacemakers and say the system was vulnerable to cyber attack.
Medical technology manufacturers have strengthened efforts to mitigate product safety issues in recent years after being warned by security researchers who have identified bugs in devices such as Medtronic implant programmers.
The shares in the company were down 1